Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor

Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis

(2022) Sana Inoue et al.   ACTA HISTOCHEMICA ET CYTOCHEMICA

L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism

(2021) Miku Sato et al.   Scientific Reports

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases

(2021) Hiroyuki Minemura et al.   Breast Cancer

Breast cancer

(2021) Sibylle Loibl et al.   LANCET

Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer

(2021) Haruhiko Shindo et al.   Cancers

Non-genomic signaling of steroid receptors in cancer

(2021) Charlène Thiebaut et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling

(2020) Ayako Kanai et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

(2020) Kimberly H. Allison et al.   JOURNAL OF CLINICAL ONCOLOGY

Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer

(2020) Shuang Ye et al.   OncoTargets and Therapy

Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases

(2019) Maria J. Contreras-Zárate et al.   ONCOGENE

Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2− Breast Cancer

(2019) Guo et al.   Cancers

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

(2018) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Intranuclear Mobility of Estrogen Receptor: Implication for Transcriptional Regulation

(2018) Ken Ichi Matsuda et al.   ACTA HISTOCHEMICA ET CYTOCHEMICA

17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib

(2016) Rainer Girgert et al.   ONCOLOGY REPORTS

Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor–positive early breast cancer in Canada

(2015) S. Djalalov et al.   Current Oncology

Novel Roles for ERK5 and Cofilin as Critical Mediators Linking ERα-Driven Transcription, Actin Reorganization, and Invasiveness in Breast Cancer

(2014) Zeynep Madak-Erdogan et al.   MOLECULAR CANCER RESEARCH

Recent insights into non-nuclear actions of estrogen receptor alpha

(2013) Subhashis Banerjee et al.   STEROIDS

Quantitative Analysis of Estrogen Receptor Expression Shows SP1 Antibody Is More Sensitive Than 1D5

(2012) Allison W. Welsh et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Cytoplasmic Estrogen Receptor in Breast Cancer

(2011) A. W. Welsh et al.   CLINICAL CANCER RESEARCH

Selective Mutations in Estrogen Receptor α D-domain Alters Nuclear Translocation and Non-estrogen Response Element Gene Regulatory Mechanisms

(2011) Katherine A. Burns et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genome-Wide Analysis of Estrogen Receptor   DNA Binding and Tethering Mechanisms Identifies Runx1 as a Novel Tethering Factor in Receptor-Mediated Transcriptional Activation

(2010) J. D. Stender et al.   MOLECULAR AND CELLULAR BIOLOGY

Genomic Collaboration of Estrogen Receptor   and Extracellular Signal-Regulated Kinase 2 in Regulating Gene and Proliferation Programs

(2010) Z. Madak-Erdogan et al.   MOLECULAR AND CELLULAR BIOLOGY

Cross-talk between non-genomic and genomic signalling pathways — Distinct effect profiles of environmental estrogens

(2010) Elisabete Silva et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY